Viewing Study NCT00017693


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2026-01-10 @ 2:07 PM
Study NCT ID: NCT00017693
Status: COMPLETED
Last Update Posted: 2016-03-07
First Post: 2001-06-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Recombinant Human IL-4 Receptor Used in Treatment of Asthma
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: DAIT Asthma 013.0014
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View